(OR) L’Oreal - Overview
Stock: Skincare, Makeup, Haircare, Fragrance, Hygiene
Dividends
| Dividend Yield | 1.80% |
| Yield on Cost 5y | 2.44% |
| Yield CAGR 5y | 15.02% |
| Payout Consistency | 99.9% |
| Payout Ratio | 61.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 26.2% |
| Relative Tail Risk | -4.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.65 |
| Alpha | 13.94 |
| Character TTM | |
|---|---|
| Beta | 0.112 |
| Beta Downside | -0.049 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.92% |
| CAGR/Max DD | 0.12 |
Description: OR L’Oreal January 28, 2026
L’Oréal S.A. (ticker OR) is a French-based, globally diversified cosmetics group that manufactures and sells a full spectrum of beauty and personal-care products through four operating divisions: Professional Products, Consumer Products, Luxe, and Dermatological Beauty.
The portfolio spans more than 30 brands-including L’Oréal Paris, Garnier, Maybelline, Lancôme, Kérastase, and CeraVe-covering skincare, make-up, hair colourants, haircare, fragrances and hygiene items, and reaches consumers via hair salons, mass-market retail, e-commerce, travel retail, pharmacies, and specialty stores.
In FY 2025 the company reported revenue of €38.5 billion, a 7 % year-over-year increase driven primarily by a 25 % share of total sales coming from e-commerce, which grew at a double-digit rate despite a modest slowdown in overall consumer spending.
R&D intensity remains high at roughly 4 % of revenue (€1.5 billion), supporting a pipeline focused on sustainable formulations and digital-first product development-key drivers in a sector where global beauty market revenue is projected to expand at a 5 % CAGR through 2028.
Raw-material cost inflation and tightening regulatory standards in the EU and North America present material headwinds, while rising disposable income in emerging markets such as India and Brazil continues to underpin long-term growth potential.
For a deeper quantitative assessment, you might explore ValueRay’s sector-specific valuation models.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 11.21b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 2.60 > 1.0 |
| NWC/Revenue: 3.75% < 20% (prev 3.46%; Δ 0.28% < -1%) |
| CFO/TA 0.22 > 3% & CFO 11.79b > Net Income 11.21b |
| Net Debt (4.01b) to EBITDA (18.35b): 0.22 < 3 |
| Current Ratio: 1.19 > 1.5 & < 3 |
| Outstanding Shares: last fiscal year (536.1m) vs prev -0.18% < -2% |
| Gross Margin: 73.80% > 18% (prev 0.74%; Δ 7306 % > 0.5%) |
| Asset Turnover: 144.3% > 50% (prev 79.42%; Δ 64.83% > 0%) |
| Interest Coverage Ratio: 27.45 > 6 (EBITDA TTM 18.35b / Interest Expense TTM 568.0m) |
Altman Z'' 4.91
| A: 0.05 (Total Current Assets 18.28b - Total Current Liabilities 15.40b) / Total Assets 54.60b |
| B: 0.41 (Retained Earnings 22.26b / Total Assets 54.60b) |
| C: 0.29 (EBIT TTM 15.59b / Avg Total Assets 53.23b) |
| D: 1.21 (Book Value of Equity 28.23b / Total Liabilities 23.42b) |
| Altman-Z'' Score: 4.91 = AAA |
Beneish M -2.68
| DSRI: 0.71 (Receivables 6.70b/5.09b, Revenue 76.78b/41.18b) |
| GMI: 1.00 (GM 73.80% / 73.89%) |
| AQI: 0.97 (AQ_t 0.56 / AQ_t-1 0.58) |
| SGI: 1.86 (Revenue 76.78b / 41.18b) |
| TATA: -0.01 (NI 11.21b - CFO 11.79b) / TA 54.60b) |
| Beneish M-Score: -2.68 (Cap -4..+1) = A |
What is the price of OR shares?
Over the past week, the price has changed by +4.98%, over one month by +9.94%, over three months by +9.71% and over the past year by +15.97%.
Is OR a buy, sell or hold?
What are the forecasts/targets for the OR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 397.8 | -0.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 417.2 | 4.4% |
OR Fundamental Data Overview February 03, 2026
P/E Trailing = 34.0368
P/E Forward = 28.3286
P/S = 4.7328
P/B = 6.6446
P/EG = 4.1355
Revenue TTM = 76.78b EUR
EBIT TTM = 15.59b EUR
EBITDA TTM = 18.35b EUR
Long Term Debt = 4.76b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.64b EUR (from shortTermDebt, last quarter)
Debt = 8.83b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.01b EUR (from netDebt column, last quarter)
Enterprise Value = 211.49b EUR (207.48b + Debt 8.83b - CCE 4.82b)
Interest Coverage Ratio = 27.45 (Ebit TTM 15.59b / Interest Expense TTM 568.0m)
EV/FCF = 22.53x (Enterprise Value 211.49b / FCF TTM 9.39b)
FCF Yield = 4.44% (FCF TTM 9.39b / Enterprise Value 211.49b)
FCF Margin = 12.22% (FCF TTM 9.39b / Revenue TTM 76.78b)
Net Margin = 14.60% (Net Income TTM 11.21b / Revenue TTM 76.78b)
Gross Margin = 73.80% ((Revenue TTM 76.78b - Cost of Revenue TTM 20.11b) / Revenue TTM)
Gross Margin QoQ = 74.67% (prev 70.48%)
Tobins Q-Ratio = 3.87 (Enterprise Value 211.49b / Total Assets 54.60b)
Interest Expense / Debt = 2.05% (Interest Expense 181.0m / Debt 8.83b)
Taxrate = 28.47% (1.34b / 4.71b)
NOPAT = 11.15b (EBIT 15.59b * (1 - 28.47%))
Current Ratio = 1.19 (Total Current Assets 18.28b / Total Current Liabilities 15.40b)
Debt / Equity = 0.28 (Debt 8.83b / totalStockholderEquity, last quarter 31.18b)
Debt / EBITDA = 0.22 (Net Debt 4.01b / EBITDA 18.35b)
Debt / FCF = 0.43 (Net Debt 4.01b / FCF TTM 9.39b)
Total Stockholder Equity = 30.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 21.06% (Net Income 11.21b / Total Assets 54.60b)
RoE = 36.45% (Net Income TTM 11.21b / Total Stockholder Equity 30.75b)
RoCE = 43.91% (EBIT 15.59b / Capital Employed (Equity 30.75b + L.T.Debt 4.76b))
RoIC = 29.16% (NOPAT 11.15b / Invested Capital 38.25b)
WACC = 6.13% (E(207.48b)/V(216.31b) * Re(6.33%) + D(8.83b)/V(216.31b) * Rd(2.05%) * (1-Tc(0.28)))
Discount Rate = 6.33% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.14%
[DCF Debug] Terminal Value 87.54% ; FCFF base≈8.66b ; Y1≈10.61b ; Y5≈17.78b
Fair Price DCF = 892.1 (EV 480.22b - Net Debt 4.01b = Equity 476.21b / Shares 533.8m; r=6.13% [WACC]; 5y FCF grow 24.08% → 2.90% )
EPS Correlation: -4.09 | EPS CAGR: -44.27% | SUE: 0.0 | # QB: 0
Revenue Correlation: 15.33 | Revenue CAGR: 18.99% | SUE: 0.81 | # QB: 0
EPS next Year (2026-12-31): EPS=13.66 | Chg30d=+0.062 | Revisions Net=+4 | Growth EPS=+6.9% | Growth Revenue=+4.5%